Charl Khalil
Cardiovascular Disease · Clearwater, FLNPI 1851755375
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.2%), grants and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Abbott at 27.0% of the total. Reporting peaked in 2023 at $24,276 and has fallen 63.3% since, to $8,919 in 2025. Among cardiovascular disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 349 payments — averaging $192.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$18K
- Biotronik Inc.$18K
- Medtronic$18K
- Boston Scientific$7K
- Medical Device Business Services, Inc.$3K
- Biosense Webster, Inc.$1K
- plus $2K from 7 others
What the payments were for
- Grants$17,66726%
- Travel & lodging$33,16149%
- Food & beverage$15,83424%
- Education$6841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 77 | $18,211 |
| Biotronik Inc. | 79 | $17,659 |
| Medtronic | 107 | $17,586 |
| Boston Scientific | 33 | $7,177 |
| Medical Device Business Services, Inc. | 25 | $3,121 |
| Biosense Webster, Inc. | 10 | $1,290 |
| Philips North America LLC | 5 | $681 |
| Cook Incorporated | 1 | $639 |
| Cook Medical LLC | 4 | $533 |
| Cardiovascular Systems Inc. | 4 | $226 |
| AstraZeneca | 1 | $101 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $96 |
| Terumo Medical Corporation | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Solia$8,644
- BioMonitor$8,644
- Acticor 7 VR-T DX$7,724
- Rivacor 7 DR-T$6,969
- Edora 8 DR-T$6,795
- ENSITE PRECISION$5,318
- Carto 3$3,814
- Micra$2,773
- Acticor$2,222
- Edora$2,222
- Rivacor$2,222
- ENSITE$1,552
- WATCHMAN Access System$1,425
- Evolution$1,121
- PAMIRA$808
- (9520) IGT Devices Undivided$385
- Plexa$373
- Sentus$373
- COBALT DR MRI SURESCAN$373
- EVERA MRI XT DR SURESCAN$261
How this compares
$67,346 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 17 | $208 |
| Doxycycline Hyclate | 22 | $119 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Clearwater
- Kevin MakatiLutz$1.6M
- Hiram BezerraTampa$698K
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
- Alan MillerJacksonville$547K
- Seth BaumBoca Raton$517K
- Elliott EliasMiami$497K
- Vijay HaryaniVero Beach$413K
- Neel PatelMaitland$392K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.